These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. PDGFRB gain-of-function mutations in sporadic infantile myofibromatosis. Arts FA; Sciot R; Brichard B; Renard M; de Rocca Serra A; Dachy G; Noël LA; Velghe AI; Galant C; Debiec-Rychter M; Van Damme A; Vikkula M; Helaers R; Limaye N; Poirel HA; Demoulin JB Hum Mol Genet; 2017 May; 26(10):1801-1810. PubMed ID: 28334876 [TBL] [Abstract][Full Text] [Related]
3. Case report: rapid and durable response to PDGFR targeted therapy in a child with refractory multiple infantile myofibromatosis and a heterozygous germline mutation of the PDGFRB gene. Mudry P; Slaby O; Neradil J; Soukalova J; Melicharkova K; Rohleder O; Jezova M; Seehofnerova A; Michu E; Veselska R; Sterba J BMC Cancer; 2017 Feb; 17(1):119. PubMed ID: 28183292 [TBL] [Abstract][Full Text] [Related]
4. Association of PDGFRB Mutations With Pediatric Myofibroma and Myofibromatosis. Dachy G; de Krijger RR; Fraitag S; Théate I; Brichard B; Hoffman SB; Libbrecht L; Arts FA; Brouillard P; Vikkula M; Limaye N; Demoulin JB JAMA Dermatol; 2019 Aug; 155(8):946-950. PubMed ID: 31017643 [TBL] [Abstract][Full Text] [Related]
5. Diagnostic limitations and considerations in the imaging evaluation of advanced multicentric infantile myofibromatosis. Parikh A; Driscoll CAH; Crowley H; York T; Dachy G; Demoulin JB; Hoffman SB Radiol Case Rep; 2020 Nov; 15(11):2440-2444. PubMed ID: 33014229 [TBL] [Abstract][Full Text] [Related]
6. PDGFRB mutants found in patients with familial infantile myofibromatosis or overgrowth syndrome are oncogenic and sensitive to imatinib. Arts FA; Chand D; Pecquet C; Velghe AI; Constantinescu S; Hallberg B; Demoulin JB Oncogene; 2016 Jun; 35(25):3239-48. PubMed ID: 26455322 [TBL] [Abstract][Full Text] [Related]
7. Genetic testing and surveillance in infantile myofibromatosis: a report from the SIOPE Host Genome Working Group. Hettmer S; Dachy G; Seitz G; Agaimy A; Duncan C; Jongmans M; Hirsch S; Kventsel I; Kordes U; de Krijger RR; Metzler M; Michaeli O; Nemes K; Poluha A; Ripperger T; Russo A; Smetsers S; Sparber-Sauer M; Stutz E; Bourdeaut F; Kratz CP; Demoulin JB Fam Cancer; 2021 Oct; 20(4):327-336. PubMed ID: 32888134 [TBL] [Abstract][Full Text] [Related]
8. A recurrent PDGFRB mutation causes familial infantile myofibromatosis. Cheung YH; Gayden T; Campeau PM; LeDuc CA; Russo D; Nguyen VH; Guo J; Qi M; Guan Y; Albrecht S; Moroz B; Eldin KW; Lu JT; Schwartzentruber J; Malkin D; Berghuis AM; Emil S; Gibbs RA; Burk DL; Vanstone M; Lee BH; Orchard D; Boycott KM; Chung WK; Jabado N Am J Hum Genet; 2013 Jun; 92(6):996-1000. PubMed ID: 23731537 [TBL] [Abstract][Full Text] [Related]
9. Treatment of generalized infantile myofibromatosis with sorafenib and imatinib: A case report. Bidadi B; Watson A; Weigel B; Oliveira A; Kirkham J; Arndt C Pediatr Blood Cancer; 2020 Jun; 67(6):e28288. PubMed ID: 32307894 [TBL] [Abstract][Full Text] [Related]
10. Infantile Myofibromatosis With Intracranial Extradural Involvement and PDGFRB Mutation: A Case Report and Review of the Literature. Al Qawahmed R; Sawyer SL; Vassilyadi M; Qin W; Boycott KM; Michaud J Pediatr Dev Pathol; 2019; 22(3):258-264. PubMed ID: 30103666 [TBL] [Abstract][Full Text] [Related]
11. Novel Hassan M; Butler E; Wilson R; Roy A; Zheng Y; Liem P; Rakheja D; Pavlick D; Young LL; Rosenzweig M; Erlich R; Ali SM; Leavey PJ; Parsons DW; Skapek SX; Laetsch TW Cold Spring Harb Mol Case Stud; 2019 Oct; 5(5):. PubMed ID: 31645346 [TBL] [Abstract][Full Text] [Related]
17. Multicentric infantile myofibromatosis with extensive involvement limited to bone. Luque-Cabal M; Obregón-Martínez E; Díez-Blanco M; Álvarez-García M; Fernández-Pérez G Skeletal Radiol; 2022 Jul; 51(7):1503-1510. PubMed ID: 34865192 [TBL] [Abstract][Full Text] [Related]
18. Effects of Sunitinib and Other Kinase Inhibitors on Cells Harboring a Sramek M; Neradil J; Macigova P; Mudry P; Polaskova K; Slaby O; Noskova H; Sterba J; Veselska R Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30200486 [TBL] [Abstract][Full Text] [Related]
19. Infantile Myofibromatosis With Cutaneous, Visceral, and CNS Involvement: A Multimodal Approach to Therapy. Gehle S; Quinsey C; McShane D; Thompson P; Quezada G J Pediatr Hematol Oncol; 2023 Oct; 45(7):e921-e923. PubMed ID: 37526359 [TBL] [Abstract][Full Text] [Related]
20. The spectrum of infantile myofibromatosis includes both non-penetrance and adult recurrence. Murray N; Hanna B; Graf N; Fu H; Mylène V; Campeau PM; Ronan A Eur J Med Genet; 2017 Jul; 60(7):353-358. PubMed ID: 28286173 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]